Literature DB >> 27552513

The Wills Eye Glaucoma App: Interest of Patients and Their Caregivers in a Smartphone-based and Tablet-based Glaucoma Application.

Michael Waisbourd1, Hermandeep Dhami, Chen Zhou, Michael Hsieh, Pramod Abichandani, Michael J Pro, Marlene R Moster, L Jay Katz, Lisa A Hark, Jonathan S Myers.   

Abstract

PURPOSE: To evaluate the interest of glaucoma patients and their caregivers in a smartphone-based and tablet-based glaucoma application (App), developed by the Wills Eye Glaucoma Research Center in collaboration with Drexel University.
MATERIALS AND METHODS: Cross-sectional survey of patients with glaucoma and their caregivers. Main outcome measures are answers to survey questions regarding how receptive participants are to using the Glaucoma App.
RESULTS: Fifty subjects completed the survey. The mean age (SD) was 59.5 (±17.3) years. A total of 88.6% of the participants lived in a household with access to a smartphone or tablet. The majority (72.3%) of participants would consider downloading the Glaucoma App, and younger participants (<65 y) were more likely to do so compared with their older (≥65 y) counterparts, P=0.025. Participants were more likely to download the App if it was free of charge, compared with a version that costs $3, P=0.018. Although only about one third (37.8%) of participants used eye drop reminders, nearly 3 of 4 (72.9%) participants were receptive to using the automated reminder feature of the Glaucoma App.
CONCLUSIONS: Glaucoma patients and their caregivers were very interested in using a Glaucoma App; however, many were not willing to spend $3 for an App they seem to value. The free Wills Eye Glaucoma App currently available on the Apple store, includes educational videos, eye drop and appointment reminders, medical and ocular data storage, visual field tutorial, and intraocular pressure tracker. These features aim to increase patients' level of knowledge about glaucoma and improve their adherence to medication and follow-up appointment recommendations.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27552513     DOI: 10.1097/IJG.0000000000000504

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  4 in total

1.  A novel EyePhone© App for improving adherence to glaucoma therapy.

Authors:  Ari Leshno; Dan Gaton; Reut Singer; Elior Eliasi; Ofri Vorobichik-Berar; Shiran Madgar; Ori Stern; Wasim Jaber; Noa Kapelushnik; Alon Skaat
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-02-02       Impact factor: 3.117

2.  A hypotonic gel-forming eye drop provides enhanced intraocular delivery of a kinase inhibitor with melanin-binding properties for sustained protection of retinal ganglion cells.

Authors:  Yoo Chun Kim; Henry T Hsueh; Matthew D Shin; Cynthia A Berlinicke; Hyounkoo Han; Nicole M Anders; Avelina Hemingway; Kirby T Leo; Renee Ti Chou; HyeYoung Kwon; Matthew B Appell; Usha Rai; Patricia Kolodziejski; Charles Eberhart; Ian Pitha; Donald J Zack; Justin Hanes; Laura M Ensign
Journal:  Drug Deliv Transl Res       Date:  2021-04-26       Impact factor: 4.617

3.  Smart Electronic Eyedrop Bottle for Unobtrusive Monitoring of Glaucoma Medication Adherence.

Authors:  Marcelo Aguilar-Rivera; Dieanira T Erudaitius; Vincent M Wu; Justin C Tantiongloc; Dae Y Kang; Todd P Coleman; Sally L Baxter; Robert N Weinreb
Journal:  Sensors (Basel)       Date:  2020-04-30       Impact factor: 3.576

4.  Perspectives and impediment to eye care in caregivers of children with childhood glaucoma.

Authors:  Aparna Rao; Niranjan Raj; Debananda Padhy; Sarada Prasanna Sarangi
Journal:  Indian J Ophthalmol       Date:  2020-05       Impact factor: 1.848

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.